Alnylam Pharmaceuticals Inc (ALNY)

HEALTH CARE: PHARMACEUTICALS
SIC: PHARMACEUTICAL PREPARATIONS

300 THIRD STREET CAMBRIDGE, MA 02142

Operates a biopharmaceutical company seeking to develop and commercialize new drugs that work through a recently discovered system in cells known as RNA interference (RNAi). Initial programs are focused on an eye disease (macular degeneration) and lung disease (respiratory syncytial virus).

Data based on most recent fiscal year report
Market Cap9.775 Billion Shares Outstanding98.33 Million Avg Volume1.733 Million
1-Yr BETA vs S&P TR1.586 Current Ratio12.23 Quick Ratio12.23
View SEC Filings from ALNY instead.
Q2 2019 All Institutions Hedge Funds 1
To trade ALNY now:
Filers who had this stock in their top 10: 7 6 (0.62%)
13F Filers holding this stock: 279 45 (4.65%)
Aggregate 13F shares on 06/30/2019: 104.685 Million 15.378 Million
Aggregate 13F shares on 03/31/2019: 95.647 Million 9.274 Million
Percent change: 9.45% 65.82%
Funds creating new positions: 38 14
Funds Adding to an existing position: 116 23
Funds closing out their position: 36 7
Funds reducing their position: 73 3
1 hedge funds as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding ALNY (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

POULTON JEFFREY V. CHIEF FINANCIAL OFFICER

  • Officer
0 2019-08-13 1

MARAGANORE JOHN CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
193,126 2019-08-06 6

GREENE BARRY E PRESIDENT

  • Officer
64,971 2019-08-06 4

VAISHNAW AKSHAY PRESIDENT, R&D

  • Officer
12,688 2019-08-06 4

KEATING LAURIE EVP, CHIEF LEGAL OFFICER

  • Officer
15,682 2019-08-06 4

GREENSTREET YVONNE CHIEF OPERATING OFFICER

  • Officer
2,323 2019-08-06 5

SANOFI

  • 10% Owner
558,035 2019-07-22 1

PAUL STEVEN M PRESIDENT & CEO

  • Officer
  • Director
106,485 2019-07-02 1

SHARP PHILIP A

  • Director
0 2019-07-01 2

SCHIMMEL PAUL

  • Director
0 2019-07-01 1

FANUCCI MARSHA

  • Director
0 2019-07-01 1

AUSIELLO DENNIS A

  • Director
0 2019-07-01 1

SCHULMAN AMY W

  • Director
0 2019-07-01 1

BONNEY MICHAEL W

  • Director
0 2019-07-01 1

PYOTT DAVID E I

  • Director
0 2019-07-01 1

REITAN COLLEEN F

  • Director
0 2019-07-01 1

HAMBURG MARGARET A

  • Director
0 2019-07-01 3

SONI MANMEET SINGH

  • Director
5,087 2019-06-13 1

SATO VICKI L

  • Director
0 2019-06-11 0

ALLEN PATRICIA L

  • Director
0 2019-06-11 0

STARR KEVIN P

0 2019-06-05 0

CLARKE JOHN K

  • Director
0 2019-05-08 0

MASON MICHAEL SVP, CFO & TREASURER

  • Officer
0 2019-02-25 1

SCHMIDT JOHN A JR

  • Director
0 2017-05-25 0

GROS DAVID-ALEXANDRE C PRESIDENT & COO

  • Officer
0 2017-02-06 0

REID LAURENCE SVP, CHIEF BUSINESS OFFICER

  • Officer
No longer subject to file 2014-12-31 0

NOVARTIS PHARMA AG

NOVARTIS AG

  • 10% Owner
No longer subject to file 2014-08-05 0

DZAU VICTOR J

18,610 2014-06-30 0

KOBLAN KENNETH S CHIEF SCIENTIFIC OFFICER

  • Officer
357 2010-12-08 0

SCOLNICK EDWARD M

  • Director
No longer subject to file 2010-07-14 0

VINCENT JAMES L

  • Director
0 2010-06-17 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

GREENSTREET YVONNE - Officer CHIEF OPERATING OFFICER

2019-08-06 A 6,250 a 25,000 2,323.00 direct

VAISHNAW AKSHAY - Officer PRESIDENT, R&D

2019-08-06 A 7,500 a 30,000 12,688.00 direct

MARAGANORE JOHN - Director - Officer CHIEF EXECUTIVE OFFICER

2019-08-06 A 16,250 a 65,000 193,126.00 direct

KEATING LAURIE - Officer EVP, CHIEF LEGAL OFFICER

2019-08-06 A 3,500 a 14,000 15,682.00 direct

GREENE BARRY E - Officer PRESIDENT

2019-08-06 A 10,000 $88.95 a 40,000 64,971.00 direct

VAISHNAW AKSHAY - Officer PRESIDENT, R&D

2019-08-06 A 6,250 a 25,000 12,688.00 direct

MARAGANORE JOHN - Director - Officer CHIEF EXECUTIVE OFFICER

2019-08-06 A 6,250 a 25,000 193,126.00 direct

KEATING LAURIE - Officer EVP, CHIEF LEGAL OFFICER

2019-08-06 A 6,250 a 25,000 15,682.00 direct

GREENE BARRY E - Officer PRESIDENT

2019-08-06 A 6,250 a 25,000 64,971.00 direct

GREENSTREET YVONNE - Officer CHIEF OPERATING OFFICER by managed account

2019-07-11 J 50 a 407 2,323.00 indirect

VAISHNAW AKSHAY - Officer PRESIDENT, R&D by managed account

2019-07-11 J 48 a 515 12,688.00 indirect

MARAGANORE JOHN - Director - Officer CHIEF EXECUTIVE OFFICER by managed account

2019-07-11 J 34 a 3,133 193,126.00 indirect

KEATING LAURIE - Officer EVP, CHIEF LEGAL OFFICER by managed account

2019-07-11 J 49 a 424 15,682.00 indirect

GREENE BARRY E - Officer PRESIDENT by managed account

2019-07-11 J 46 a 3,003 64,971.00 indirect

BONNEY MICHAEL W - Director

2019-07-01 A 9,000 a 9,000 0.00 direct

SCHULMAN AMY W - Director

2019-07-01 A 9,000 a 9,000 0.00 direct

PAUL STEVEN M - Director

2019-07-01 A 9,000 a 9,000 0.00 direct

AUSIELLO DENNIS A - Director

2019-07-01 A 9,000 a 9,000 0.00 direct

SCHIMMEL PAUL - Director

2019-07-01 A 9,000 a 9,000 0.00 direct

HAMBURG MARGARET A - Director

2019-07-01 A 9,000 a 9,000 0.00 direct

PYOTT DAVID E I - Director

2019-07-01 A 9,000 a 9,000 0.00 direct

SHARP PHILIP A - Director

2019-07-01 A 9,000 a 9,000 0.00 direct

REITAN COLLEEN F - Director

2019-07-01 A 9,000 a 9,000 0.00 direct

FANUCCI MARSHA - Director

2019-07-01 A 9,000 a 9,000 0.00 direct
Click here to report any possible errors with this stock listing.

Elevate your investments